Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1983 1
1984 1
1985 2
1986 2
1987 1
1990 3
1991 2
1992 2
1994 4
1995 2
1996 3
1997 2
1998 3
1999 2
2000 2
2001 3
2004 1
2005 1
2006 2
2007 2
2009 6
2010 2
2011 3
2012 2
2013 6
2014 6
2015 5
2016 5
2017 2
2018 4
2019 6
2020 4
2021 5
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Pleural Effusion and Its Current Management: A Review.
Skok K, Hladnik G, Grm A, Crnjac A. Skok K, et al. Medicina (Kaunas). 2019 Aug 15;55(8):490. doi: 10.3390/medicina55080490. Medicina (Kaunas). 2019. PMID: 31443309 Free PMC article. Review.
Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a common symptom and accompanying manifestation of metastatic disease. It affects up to 15% of all patients with cancer and is the most common in lung, breast cancer, lymph …
Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a common symptom and accompanying manif …
Immunochemistry in the work-up of mesothelioma and its differential diagnosis and mimickers.
Mneimneh WS, Jiang Y, Harbhajanka A, Michael CW. Mneimneh WS, et al. Diagn Cytopathol. 2021 May;49(5):582-595. doi: 10.1002/dc.24720. Epub 2021 Mar 6. Diagn Cytopathol. 2021. PMID: 33675675 Review.
The differential diagnosis in cellular effusions with cytological atypia often includes malignant mesothelioma (MM), reactive mesothelial proliferation, and malignancies of metastatic origin, particularly carcinomas. ...Utilizing a panel of markers, IC allows …
The differential diagnosis in cellular effusions with cytological atypia often includes malignant mesothelioma (MM), reactive …
Principles of Surgical Management of Peritoneal Mesothelioma.
Steadman JA, Grotz TE. Steadman JA, et al. J Natl Compr Canc Netw. 2023 Sep;21(9):981-986. doi: 10.6004/jnccn.2023.7055. J Natl Compr Canc Netw. 2023. PMID: 37673112 Review.
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy and represents 5% to 30% of malignant mesothelioma cases. ...Contraindications to curative intent surgery include the sarcomatoid MPeM, distant metastases, extensive nodal metastases, and ex …
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy and represents 5% to 30% of malignant mesothelioma …
Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma.
Alexander HR Jr, Li CY, Kennedy TJ. Alexander HR Jr, et al. Ann Surg Oncol. 2018 Aug;25(8):2159-2164. doi: 10.1245/s10434-018-6337-5. Epub 2018 Feb 8. Ann Surg Oncol. 2018. PMID: 29423664 Review.
PURPOSE: Diffuse malignant peritoneal mesothelioma (MPM) is a rare and ultimately fatal cancer that was first described just over a century ago. ...Studies on the molecular biology of MPM have yielded new insights relating to the potentially important role of the ph …
PURPOSE: Diffuse malignant peritoneal mesothelioma (MPM) is a rare and ultimately fatal cancer that was first described just o …
Malignant pleural mesothelioma: an update on diagnosis and treatment options.
Kondola S, Manners D, Nowak AK. Kondola S, et al. Ther Adv Respir Dis. 2016 Jun;10(3):275-88. doi: 10.1177/1753465816628800. Epub 2016 Feb 12. Ther Adv Respir Dis. 2016. PMID: 26873306 Free PMC article. Review.
Malignant pleural mesothelioma (MPM) represents a significant diagnostic and therapeutic challenge and is almost always a fatal disease. Imaging abnormalities are common, but have a limited role in distinguishing mesothelioma from metastatic ple …
Malignant pleural mesothelioma (MPM) represents a significant diagnostic and therapeutic challenge and is almost always …
Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F. Rodríguez Panadero F. Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22. Arch Bronconeumol. 2015. PMID: 25059587 Review. English, Spanish.
There are three major challenges in the diagnosis of malignant pleural mesothelioma: mesothelioma must be distinguished from benign mesothelial hyperplasia; malignant mesothelioma (and its subtypes) must be distinguished from metastatic c …
There are three major challenges in the diagnosis of malignant pleural mesothelioma: mesothelioma must be distinguished …
Pathohistological diagnosis and differential diagnosis.
Tischoff I, Neid M, Neumann V, Tannapfel A. Tischoff I, et al. Recent Results Cancer Res. 2011;189:57-78. doi: 10.1007/978-3-642-10862-4_5. Recent Results Cancer Res. 2011. PMID: 21479896 Review.
Malignant mesothelioma occurs predominantly in men (>90%). Asbestos exposure is the best known and evaluated risk factor with a long latency period between exposure and onset of malignant mesothelioma ranging from 15 to 60 years. ...Histological typ …
Malignant mesothelioma occurs predominantly in men (>90%). Asbestos exposure is the best known and evaluated risk factor wi …
A Clinico-Pathologic Approach to the Differential Diagnosis of Pericardial Tumors.
Krywanczyk AR, Tan CD, Rodriguez ER. Krywanczyk AR, et al. Curr Cardiol Rep. 2021 Jul 16;23(9):119. doi: 10.1007/s11886-021-01548-6. Curr Cardiol Rep. 2021. PMID: 34269901 Review.
Pericardial tumors can be categorized as non-neoplastic or neoplastic. Neoplastic lesions can be further divided into benign or malignant, with malignancies being either primary or secondary (metastatic). ...Of primary pericardial malignancies, mesotheliom …
Pericardial tumors can be categorized as non-neoplastic or neoplastic. Neoplastic lesions can be further divided into benign or malignant …
Treatment of Platinum Nonresponsive Metastatic Malignant Peritoneal Mesothelioma With Combination Chemoimmunotherapy.
Foote MB, Shia J, Zauderer MG, Nash GM, Cercek A. Foote MB, et al. J Immunother. 2022 Feb-Mar 01;45(2):100-103. doi: 10.1097/CJI.0000000000000399. J Immunother. 2022. PMID: 34723916 Free PMC article.
Malignant peritoneal mesothelioma is a rare cancer associated with minimal durable disease control with chemotherapy and poor overall survival. The efficacy of combined cytotoxic chemotherapy and immune checkpoint inhibitors (ICIs) in malignant peritoneal …
Malignant peritoneal mesothelioma is a rare cancer associated with minimal durable disease control with chemotherapy and poor …
Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2.
Chokoeva AA, Tchernev G, Cardoso JC, Patterson JW, Dechev I, Valkanov S, Zanardelli M, Lotti T, Wollina U. Chokoeva AA, et al. Int J Immunopathol Pharmacol. 2015 Jun;28(2):178-86. doi: 10.1177/0394632015575977. Epub 2015 Mar 26. Int J Immunopathol Pharmacol. 2015. PMID: 25816393 Free article. Review.
They are characterized by rapid growth, high metastatic potential, frequent recurrences, aggressive behavior, and high mortality rate. In Part 1 of this paper, we presented the most common forms of sarcoma of the vulva: leiomyosarcoma, epithelioid sarcoma, malignant …
They are characterized by rapid growth, high metastatic potential, frequent recurrences, aggressive behavior, and high mortality rate …
95 results